Member Info for ontarget

Here's a more detailed version of the article Moneymuch pasted:
https://news.umich.edu/glioblastoma-nanomedicine-crosses-into-brain-in-mice-eradicates-recurring-brain-cancer/
It doesn't read to me like they have collaborated with Evgen, but happy to be proved wrong.

"The work was supported by the National Institutes of Health and National Institute of Neurological Disorders & Stroke, the Dr. Ralph and Marian Falk Medical Research Trust – Catalyst Awards Program, U-M Department of Neurosurgery, U-M Biointerfaces Institute, Leah’s Happy Hearts, ChadTough Foundation and Smiles for Sophie Forever Foundation. U-M has applied for patent protection"

Even if Evgen can't be named for some strange reason, surely they would at least say "and an unnamed private company" or similar.

Given the article that you referenced was released, it would seem a bit strange that EVG couldn't release something as well? It's not like it's been kept a secret?

Fresh off the press https://youtu.be/Pg2x00c9umM

Seems genuine as well - can sell easily at the offer price but buy nothing - what a change from a few weeks ago.

And only got 160k by the look of it - encouraging sign.

410k buy order at 9.1p in the closing auction

Spot the sellers lol.

Looks like the MM's are up for a rise here.

I wonder if the new CEO will take this opportunity to buy some stock in the market, now that the closed period is out of the way and up-to-date info has been published?

Mudstud, the sp is in $. It had a $60m market cap and is now nearly $700m after the news.

Yes this is insultingly cheap - a p*ss take.

Selling again *sigh*. What is wrong with this stock?

I think more like people randomly buying rising shares for a 'trade' without doing any research. This is clearly not a good one for a day trade with its lumpy volume and unpredictable MM movements/shenanigans.

Some of these sells match with buys on Friday. Not sure why people bother buying a stock and then selling it the next trading day for a loss - obviously no clue what they were buying.

Why is EVG so very cheap - is it that the market doesn't believe in the potential of SFX-01/other analogues?
Positive results in the current ARDS/COVID trial could have a double-whammy effect and cause a re-evalulation of EVG's other promising applications.

Interesting - so Moneymunch is the seller jimbren??

No, printing mistake - the trade got deleted

https://www.lse.co.uk/ShareTrades.asp?shareprice=EVG&share=Evgen-Pharma

Closing the gap down from 8.6 on the 10th would be a good starting point before that as well.

https://lcnlegal.com/what-are-loan-notes/
“Redemption” means repayment of a loan note – in other words, when the issuer pays all outstanding principal and interest, and the loan note is cancelled.

What 36 month period, are you referring to this?

" § Each tranche of Convertible Loan Notes issued is redeemable at par on the date falling 36 months after the relevant Issue Date (the "Maturity Date"). "

This is when HEMO can pay back the loan notes in cash, nothing to do with conversion by the holder.